Trimodality Therapy COE

The Role of Bladder-Sparing Trimodality Therapy - Sophia Kamran Details Sophia Kamran joins Sam Chang to discuss her presentation from the GU ASCO 2022 Annual Meeting focusing on novel therapies in bladder cancer and their toxicities, discussing the role of bladder-sparing trimodality therapy with a focus on toxicity and functional outcomes. Biographies: Sophia C. Kamran, MD, Assistant Professor of Radiation Oncology, Harvard Medical School, Massachusetts General Hosp...
Comparative Effectiveness of Radical Cystectomy and Trimodality Therapy for Muscle-Invasive Bladder Cancer – Boris Gershman Details In a discussion hosted by Ashish Kamat, Boris Gershman presents his study comparing radical cystectomy and trimodality therapy for muscle-invasive urothelial carcinoma of the bladder. The study aims to fill a significant knowledge gap, as no randomized trials have directly compared these treatments. Using an emulation framework to replicate the UK's SPARE trial, which closed due to low recruitment...

The Role of Bladder-Sparing Trimodality Therapy - Sophia Kamran